Log in to save to my catalogue

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141844

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

About this item

Full title

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

Publisher

Vienna: Springer Vienna

Journal title

Archives of virology, 2023-05, Vol.168 (5), p.147-147, Article 147

Language

English

Formats

Publication information

Publisher

Vienna: Springer Vienna

More information

Scope and Contents

Contents

Hepatitis E virus (HEV) is endemic in several developing countries of Africa and Asia. It mainly causes self-limiting waterborne infections, in either sporadic or outbreak form. Recently, HEV was shown to cause chronic infections in immunosuppressed individuals. Ribavirin and interferon, the current off-label treatment options for hepatitis E, have...

Alternative Titles

Full title

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141844

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141844

Other Identifiers

ISSN

0304-8608

E-ISSN

1432-8798

DOI

10.1007/s00705-023-05770-1

How to access this item